tiprankstipranks

Catherine Szyman Insider Profile

11 Followers
Catherine Szyman, CVP, Critical Care at Edwards Lifesciences, holds 22.43K shares in Inari Medical (Ticker: NARI), holds 43.37K shares in Edwards Lifesciences (Ticker: EW), holds 24.60K shares in Outset Medical (Ticker: OM).
tipranks
Catherine Szyman

Catherine Szyman
Edwards Lifesciences (EW)
CVP, Critical Care

Ranked #31,722 out of 98,624 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+5.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
58.65%
26.95%
13.48%
0.92%
A breakdown of Catherine Szyman's holdings

Insider Roles

Edwards Lifesciences
(EW)
CVP, Critical Care
Medtronic
(MDT)
SrVP & Pres Diabetes
Inari Medical
(NARI)
Director
Outset Medical
(OM)
Director
Roles that Catherine Szyman holds in companies

Most Profitable Insider Trade

Stock:
Inari Medical
(NARI)
Rating:Informative Buy
Date:May 27, 2020 - May 27, 2021
Return:+106.50%
The most profitable trade made by Catherine Szyman

Catherine Szyman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Edwards Lifesciences
Feb 23, 2024
CVP, Critical Care
Uninformative Buy
$3.75M
Inari Medical
Apr 26, 2024
Director
Uninformative Buy
174.98K
$861.72K
Outset Medical
May 31, 2023
Director
Uninformative Buy
$59.03K
Medtronic
Apr 21, 2014
SrVP & Pres Diabetes
Uninformative Sell
1.73M
$1.72M
List of latest transactions for each holding click on a transaction to see Catherine Szyman's performance on stock

Catherine Szyman insider profile FAQ

What is the percentage of profitable transactions made by Catherine Szyman?
The percentage of profitable transactions made by Catherine Szyman is 40%.
    What is the average return per transaction made by Catherine Szyman?
    The average return per transaction made by Catherine Szyman is 5.60%.
      What stocks does Catherine Szyman hold?
      Catherine Szyman holds: EW, NARI, OM, MDT stocks.
        What was Catherine Szyman’s latest transaction?
        Catherine Szyman latest transaction was an Uninformative Buy of $174.98K.
          What was Catherine Szyman's most profitable transaction?
          Catherine Szyman’s most profitable transaction was an Informative Buy of NARI stock on May 27, 2020. The return on the trade was 106.50%.
            What is Catherine Szyman's role in Edwards Lifesciences?
            Catherine Szyman's role in Edwards Lifesciences is CVP, Critical Care.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.